IRISanRaf

PICCONI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.403
AS - Asia 3.205
EU - Europa 945
SA - Sud America 339
AF - Africa 76
Continente sconosciuto - Info sul continente non disponibili 68
OC - Oceania 16
Totale 9.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.949
TR - Turchia 951
SG - Singapore 891
CN - Cina 813
CA - Canada 412
IT - Italia 389
BR - Brasile 266
VN - Vietnam 180
CZ - Repubblica Ceca 120
DE - Germania 102
GB - Regno Unito 84
HK - Hong Kong 77
EU - Europa 67
BD - Bangladesh 62
IN - India 58
FR - Francia 51
IE - Irlanda 45
PK - Pakistan 34
MX - Messico 28
ZA - Sudafrica 27
NL - Olanda 23
JP - Giappone 21
AR - Argentina 20
CO - Colombia 19
RU - Federazione Russa 19
FI - Finlandia 18
IL - Israele 18
ES - Italia 15
EC - Ecuador 14
PL - Polonia 14
ID - Indonesia 13
UA - Ucraina 13
IQ - Iraq 12
MA - Marocco 10
RO - Romania 10
AU - Australia 9
SE - Svezia 9
SA - Arabia Saudita 8
JO - Giordania 7
PH - Filippine 7
CL - Cile 6
DK - Danimarca 6
KE - Kenya 6
MY - Malesia 6
NZ - Nuova Zelanda 6
SC - Seychelles 6
TW - Taiwan 6
DZ - Algeria 5
EG - Egitto 5
PS - Palestinian Territory 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
NI - Nicaragua 4
PE - Perù 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
GR - Grecia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
RS - Serbia 3
SN - Senegal 3
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
IR - Iran 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
NG - Nigeria 2
UY - Uruguay 2
AT - Austria 1
BY - Bielorussia 1
CH - Svizzera 1
DJ - Gibuti 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 9.045
Salva come PNG Salva come JPEG
Città #
Kocaeli 807
San Mateo 688
San Jose 530
Toronto 374
Ashburn 351
Dallas 279
Singapore 258
Wilmington 202
Beijing 183
Rome 183
Houston 182
Santa Clara 166
Chandler 159
Lawrence 139
Princeton 139
Olomouc 119
Fairfield 84
Hong Kong 73
Ho Chi Minh City 64
Shanghai 59
Seattle 51
Woodbridge 48
Hanoi 43
Los Angeles 43
Guangzhou 37
Munich 35
Redwood City 34
São Paulo 30
Chicago 27
Islamabad 27
The Dalles 25
Columbus 23
Dublin 23
Shenzhen 23
Cambridge 22
Frankfurt am Main 22
New York 22
Brooklyn 21
Council Bluffs 21
Falls Church 19
Chennai 16
Orem 16
Tokyo 16
Jiaxing 15
London 15
Mexico City 15
Netanya 15
Johannesburg 14
Helsinki 13
Milan 12
Pune 12
Belo Horizonte 11
Ningbo 11
Wuhan 11
Boston 10
Constanta 10
Montreal 9
Rio de Janeiro 9
Dhaka 8
Guayaquil 8
Mumbai 8
Stockholm 8
Amman 7
Bogotá 7
Charlotte 7
Haiphong 7
Rui'an 7
Wroclaw 7
Amsterdam 6
Buffalo 6
Da Nang 6
Dongyang 6
Florence 6
Wuxi 6
Atlanta 5
Biên Hòa 5
Bristol 5
Guarulhos 5
Haining 5
Jakarta 5
Manaus 5
Medellín 5
Nairobi 5
Padova 5
Phoenix 5
Saint Louis 5
Tashkent 5
Trento 5
Warsaw 5
Washington 5
Ankara 4
Boardman 4
Cagliari 4
Casablanca 4
Curitiba 4
Espoo 4
Genoa 4
Joinville 4
Kuala Lumpur 4
Madrid 4
Totale 6.095
Salva come PNG Salva come JPEG
Nome #
Direct and indirect pathways of basal ganglia: a critical reappraisal 235
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 155
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation 124
Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons 104
Corrigendum: Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons 103
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 103
Quantal release of dopamine and action potential firing detected in midbrain neurons by multifunctional diamond-based microarrays 94
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 93
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions. 88
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. 85
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease 84
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior 84
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. 82
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuo-spatial memory alteration. 82
Dopamine drives binge-like consumption of a palatable food in experimental parkinsonism. 79
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission 78
Synaptic dysfunction in Parkinson's disease 76
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 76
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease 75
Interaction between basal ganglia and limbic circuits in learning and memory processes 74
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 74
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 73
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 72
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 71
Striatal spreading depolarization: possible implication in L-DOPA-induced dyskinetic like-behavior. 71
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 71
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 71
Neuroinflammation and Dyskinesia: A Possible Causative Relationship? 70
Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities 70
Motor Complications in Parkinson's Disease: Striatal Molecular and Electrophysiological Mechanisms of Dyskinesias 70
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 69
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease 69
NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology 68
Serotonin drives striatal synaptic plasticity in a sex-related manner 68
Theta-burst stimulation and striatal plasticity in experimental parkinsonism 66
Role of tonically-active neurons in the control of striatal function: Cellular mechanisms and behavioral correlates 66
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment 66
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias 66
N-Methyl-D-aspartate (NMDA) Receptor Composition Modulates Dendritic Spine Morphology in Striatal Medium Spiny Neurons 66
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 65
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 65
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 65
Dopaminergic control of synaptic plasticity in the dorsal striatum 64
Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine 64
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 64
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia 64
Dopamine-mediated regulation of corticostriatal synaptic plasticity. 64
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 64
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D-2/A(2A) Receptor Interaction in the Striatum: Implications for Parkinson's Disease 64
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of L-Dopa-induced dyskinesia 63
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 63
Prenatal stress and hippocampal BDNF expression: a fading imperative 63
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion 63
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity 63
Striatum-hippocampus balance: From physiological behavior to interneuronal pathology 62
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate 1-DOPA-induced dyskinesia 62
Early Synaptic Dysfunction in Parkinson's Disease: Insights From Animal Models 62
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. 61
New Synaptic and Molecular Targets for Neuroprotection in Parkinson's Disease 61
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 61
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease 61
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 60
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 60
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 60
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 60
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 60
Mechanisms underlying dopaminergic control of cortico-striatal synaptic transmission 59
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia 59
L-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via beta-adrenergic receptors 59
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 59
Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons 59
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. 59
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice 58
Neural networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 58
Tissue plasminogen activator is required for corticostriatal long-term potentiation 57
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. 57
Unilateral dopamine denervation blocks corticostriatal LTP 57
Mechanisms underlying altered striatal synaptic plasticity in old A53T-alpha synuclein overexpressing mice 57
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease 57
Hyperkinetic disorders and loss of synaptic downscaling 57
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 56
FUNCTIONAL INTERACTIONS WITHIN STRIATAL MICROCIRCUIT IN ANIMAL MODELS OF HUNTINGTON'S DISEASE 56
Rhes-mTORC1 interaction: A new possible therapeutic target in Parkinson's disease and L-dopa-induced dyskinesia? 56
NR2B subunit exerts a critical role in postischemic synaptic plasticity. 56
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 56
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP 56
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. 56
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 55
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia 55
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 55
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 55
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 55
Basic mechanisms of plasticity and learning 54
Plasticity and repair in the post-ischemic brain. 54
Molecular mechanisms underlying levodopa-induced dyskinesia. 54
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression 54
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 53
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition 53
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 53
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity 53
Totale 6.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.899
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 0 53
2021/20221.349 11 369 372 1 9 12 89 139 36 279 11 21
2022/2023647 308 15 13 54 33 16 5 21 29 63 82 8
2023/2024571 0 2 17 127 26 17 15 37 3 21 70 236
2024/20251.466 54 338 98 68 92 234 41 98 191 20 58 174
2025/20263.286 258 244 298 236 231 382 490 249 275 454 79 90
Totale 9.305